SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Part VII Transfer & Board changes

7 Apr 2026 07:00

RNS Number : 3199Z
Nationwide Building Society
07 April 2026
 

Nationwide Building Society (Nationwide), Virgin Money UK PLC (Virgin Money) and Clydesdale Bank PLC (CB)

Transfer of banking business under Part VII of the Financial Services and Markets Act 2000 and Board changes

Nationwide announces the completion of a banking business transfer scheme (the "Scheme") under Part VII of the Financial Services and Markets Act 2000. This provided for the transfer of the Transferring Business of CB (as defined in the document setting out the terms of the Scheme (the "Scheme Document")) to Nationwide. The Transferring Business consists of the entire business of CB (except for a small number of products, contracts and arrangements, which constitute the Excluded Business (as defined in the Scheme Document)).

The Scheme took effect on 2 April 2026 at 23:59.

A copy of the Scheme Document and other documents relating to the Scheme are available on CB's website at virginmoney.com/nationwide-transfer.

Nationwide further announces that, after first joining the Nationwide Board in April 2009, Chris Rhodes, Virgin Money CEO, will retire from the Boards of Nationwide, Virgin Money and CB (the Board) as an Executive Director on 21 May 2026, before retiring from the Nationwide business entirely in September 2026.

Dame Debbie Crosbie DBE, Group CEO, said: "I would like to thank Chris for his exceptional service to UK financial services. Chris's impact across Nationwide and Virgin Money has been immense. He has been with Nationwide since 2009, and he steadied and strengthened the Virgin Money business as its CEO over the past 18 months. As a result, we are very well positioned for the future."

Additionally, Alan Keir will retire as Non-Executive Director and Chair of the Board Risk Committee on 16 July 2026 following Nationwide's Annual General Meeting (AGM) on 15 July 2026. Phil Rivett, Non-Executive Director and current Chair of the Audit Committee, will succeed Alan as Board Risk Committee Chair, subject to regulatory approval. As previously announced, Guy Bainbridge will become Chair of the Audit Committee following the AGM, subject to regulatory approval.

Kevin Parry OBE, Chairman, said: "I would like to express my thanks to Alan for his outstanding service and leadership as Chair of the Board Risk Committee, and for the considerable expertise he has brought to the Board through a period of significant organisational change. I am pleased to welcome Phil as the next Chair of the Board Risk Committee, who will provide continuity as governance responsibilities evolve."

 

For further information, please contact:

 

Investors and Analysts

Vikas Sidhu

nationwide.treasury@nationwide.co.uk

Society Secretary

Jason Wright

jason.wright2@nationwide.co.uk

Media Relations

Sara Batchelor

press.office@nationwide.co.uk

 

About Nationwide

Nationwide is the world's largest building society. Following its acquisition of Virgin Money, Nationwide is connected with one in three people in the UK and is the second largest provider of mortgages and retail deposits. It is also a major provider of current accounts, credit cards, personal loans and business banking. Customers can choose to manage their finances in a branch, via mobile app, the internet, telephone, and post. Nationwide has around 25,000 employees and its head office is in Swindon, UK.

As a financial services provider owned by its members, not shareholders, Nationwide's purpose is: Banking - but fairer, more rewarding, and for the good of society. For more information see nationwide.co.uk/about-us

7 April 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUPUCUPQGAP
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.